Goosehead Insurance, Inc

GSHD · NASDAQ

Low target$37.00
Average target$73.00
High target$140.00

Analyst ratings

buy · 11 ratings

DateFirmActionRatingPrice target
July 15, 2026Piper SandlerMaintainsOverweight$72.00
July 13, 2026JP MorganMaintainsNeutral$60.00
July 13, 2026RBC CapitalMaintainsSector Perform$55.00
July 9, 2026Cantor FitzgeraldMaintainsOverweight$76.00
July 8, 2026UBSMaintainsBuy$70.00
June 9, 2026UBSMaintainsBuy$67.00
May 26, 2026Piper SandlerMaintainsOverweight$52.00
May 14, 2026JP MorganMaintainsNeutral$55.00
April 27, 2026UBSMaintainsBuy$85.00
April 23, 2026RBC CapitalMaintainsSector Perform$52.00
April 23, 2026Piper SandlerMaintainsOverweight$60.00
April 23, 2026Keefe, Bruyette & WoodsMaintainsOutperform$80.00
April 14, 2026B of A SecuritiesMaintainsUnderperform$37.00
April 13, 2026CitizensMaintainsMarket Outperform$100.00
April 9, 2026JP MorganMaintainsNeutral$58.00
April 9, 2026Cantor FitzgeraldMaintainsOverweight$67.00
April 8, 2026UBSMaintainsBuy$81.00
April 7, 2026Keefe, Bruyette & WoodsMaintainsOutperform$75.00
February 23, 2026UBSMaintainsBuy$90.00
February 23, 2026JP MorganMaintainsNeutral$68.00
February 18, 2026BMO CapitalMaintainsMarket Perform$55.00
February 18, 2026Truist SecuritiesMaintainsHold$58.00
February 18, 2026CitizensMaintainsMarket Outperform$125.00
February 18, 2026Keefe, Bruyette & WoodsMaintainsOutperform$85.00
February 18, 2026Piper SandlerUpgradesOverweight$69.00
January 14, 2026Cantor FitzgeraldMaintainsOverweight$111.00
January 7, 2026JP MorganMaintainsNeutral$80.00
November 25, 2025BMO CapitalMaintainsMarket Perform$79.00
October 27, 2025UBSMaintainsBuy$121.00
October 23, 2025Truist SecuritiesMaintainsHold$72.00
October 23, 2025Keefe, Bruyette & WoodsMaintainsOutperform$95.00
October 23, 2025Piper SandlerMaintainsNeutral$69.00
October 14, 2025JMP SecuritiesMaintainsMarket Outperform$140.00
October 9, 2025JP MorganMaintainsNeutral$85.00
October 8, 2025UBSMaintainsBuy$130.00
October 6, 2025Piper SandlerMaintainsNeutral$79.00
September 23, 2025Truist SecuritiesMaintainsHold$85.00
September 2, 2025Piper SandlerMaintainsNeutral$92.00

Revenue growth trajectory and financial performance sustainability

Bull case

New business commissions grew 29% in Q1 2026 — the fastest pace in nearly five years — and management reiterated full-year guidance of 10% to 19% total revenue growth, with acceleration expected in the second half as client retention improvements flow through. The underlying business momentum suggests a compelling recovery.

Bear case

Despite earnings beating estimates, Q1 2026 revenue of $79.48 million came in significantly below analyst expectations of $105.16 million. Bank of America maintained an underperform rating with a reduced price target of $37, reflecting skepticism about whether reported growth translates into consistent top-line delivery.

AI strategy and technology transformation under new CTO Eben Hewitt

Bull case

The appointment of Eben Hewitt as CTO signals a concrete near-term catalyst around AI and Digital Agent 2.0 execution. The most optimistic analysts model revenue reaching $696 million by 2029, assuming Goosehead's AI marketplace materially reshapes margins and market share well above baseline projections.

Bear case

Hewitt's appointment does not materially change the core risk: whether Goosehead can defend its independent-agent model against digital disintermediation. The AI narrative alone is insufficient, as the company's removal from the S&P Insurance Select Industry Index weighs on sentiment for a stock already experiencing weak multi-year returns.

Stock valuation and price target divergence amid steep share price decline

Bull case

With GSHD down 58% over the last 12 months despite 16.2% revenue growth, several analysts see deep undervaluation. Keefe, Bruyette & Woods rates the stock outperform with an $80 target, UBS maintains a Buy with a $70 target, and a discounted model projects a 110.2% total return to $91.22 by December 2028.

Bear case

JPMorgan and Royal Bank of Canada both maintain neutral or sector perform ratings, with price targets of $60 and $55 respectively — well below the consensus average. The stock's historical P/E compression and elevated short interest of over 11% suggest significant investor skepticism about a near-term re-rating.